Intech Biopharm (ROCO:6461) 5-Year EBITDA Growth Rate : 6.20% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Intech Biopharm 5-Year EBITDA Growth Rate?

Intech Biopharm's EBITDA per Share for the three months ended in Dec. 2023 was NT$-0.52.

During the past 3 years, the average EBITDA Per Share Growth Rate was -8.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Intech Biopharm was 21.90% per year. The lowest was -26.00% per year. And the median was -6.30% per year.

Competitive Comparison of Intech Biopharm's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Intech Biopharm's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intech Biopharm's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intech Biopharm's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Intech Biopharm's 5-Year EBITDA Growth Rate falls into.

Intech Biopharm 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Intech Biopharm (ROCO:6461) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Intech Biopharm 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Intech Biopharm's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Intech Biopharm (ROCO:6461) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intech Biopharm Ltd (ROCO:6461) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ruiguang Road, Neihu District, 3rd Floor, No. 36, Lane 358, Neihu, Taipei, TWN

Website

http://www.intechbiopharm.com

Intech Biopharm Ltd is a biotechnology company. The company develops inhalation products including single or combination generic products and some new combinations or new formulation projects are under development. It develops drugs for the treatment of lung diseases such as asthma.

Intech Biopharm (ROCO:6461) Headlines

No Headlines